U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07815860) titled '18F-S2P PET Imaging in the Evaluation of Large Artery Atherosclerosis' on Aug. 24.
Brief Summary: The aim of this study is to evaluate the lesion detection performance and safety of 18F-S2P positron emission tomography (PET) in patients with large-artery atherosclerosis.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Large-Artery Atherosclerosis (Embolus/Thrombosis)
Intervention:
DRUG: 18F-S2P
Patients with large-artery atherosclerosis receive 3.7 MBq/kg of 18F-S2P intravenously followed by PET/CT after 30 min of injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: First Affiliated Hospital of Zh...